(FDT) Developed Markets Ex-US - NASDAQ
ETF Category: Foreign Large Value | Exchange: NASDAQ (USA) | Market Cap: 1.280m USD | Total Return: 48.2% in 12m
Avg Turnover: 10.9M
Warnings
No concerns identified
Tailwinds
No distinct edge detected
The First Trust Developed Markets Ex-US AlphaDEX® Fund (FDT) is an exchange-traded fund that tracks the NASDAQ AlphaDEX® Developed Markets Ex-US Index. The fund allocates at least 90% of its net assets to securities within this index, targeting equities in developed economies outside of the United States.
The fund utilizes a proprietary AlphaDEX® selection methodology, a quantitative strategy designed to identify stocks with the potential for higher risk-adjusted returns compared to market-cap-weighted benchmarks. This approach categorizes the fund within the Foreign Large Value sector, which typically focuses on established international companies with low price-to-book or price-to-earnings ratios. Investors often use these vehicles to gain exposure to non-U.S. revenue streams and diversify currency risk.
Analyzing fundamental metrics on ValueRay can provide deeper insight into how this methodology performs across different market cycles. Detailed historical performance and expense ratio data are essential components for evaluating the long-term viability of this quantitative strategy.
- Monetary policy shifts in non-US developed economies impact currency-adjusted returns
- Global trade volume fluctuations influence export-oriented multinational constituent revenues
- Quantitative factor performance determines index alpha relative to market-cap benchmarks
- Relative economic growth rates in Europe and Pacific regions drive capital inflows
- Foreign exchange volatility affects net asset value for dollar-based investors
As of June 15, 2026, the stock is trading at USD 97.54 with a total of 115,721 shares traded.
Over the past week, the price has changed by +3.55%,
over one month by -1.97%,
over three months by +10.19% and
over the past year by +48.23%.
Developed Markets Ex-US has no consensus analysts rating.